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Abstract
Methionine adenosyltransferase (MAT) catalyzes the biosynthesis of S-adenosylmethionine (AdoMet). In
mammals MAT activity derives from two separate genes which display a tissue-specific pattern of expression.
While MAT1A is expressed only in the adult liver, MAT2A is expressed in non-hepatic tissues. The mechanisms
behind the selective expression of these two genes are not fully understood. In the present report we have
evaluated MAT1A and MAT2A methylation in liver and in other tissues, such as kidney, by methylation-
sensitive restriction enzyme digestion of genomic DNA. Our data indicate that MAT1A is hypomethylated in
liver and hypermethylated in non-expressing tissues. The opposite situation is found for MAT2A. Additionally,
histones associated to MAT1A and MAT2A genes showed enhanced levels of acetylation in expressing tissues
(two-fold for MAT1A and 3.5-fold for MAT2A liver and kidney respectively). These observations support a role
for chromatin structure and its modification in the tissue-specific expression of both MAT genes. # 2000
Elsevier Science Ltd. All rights reserved.
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1. Introduction
Methionine adenosyltransferase (MAT; ATP:L-
methionine S-adenosyltransferase, EC 2.5.1.6)
catalyzes the biosynthesis of AdoMet from meth-
The International Journal of Biochemistry & Cell Biology 32 (2000) 397–404




LT and GLR made equal contribution to this work.
* Corresponding author. Tel.: +34-948-425678; fax: +34-
948-425677.
E-mail address: jmmato@unav.es (J.M. Mato).
ionine and ATP [1]. AdoMet is the major methyl
group donor in transmethylation reactions and
serves as the propylamino source in the biosyn-
thesis of polyamines [2]. In mammals, this essen-
tial enzyme is the product of two dierent genes,
MAT1A and MAT2A, which display a distinct
pattern of expression among dierent tissues
[2,3]. MAT1A is the predominant enzyme in liver
parenchymal cells, while MAT2A is expressed in
all other tissues, in the fetal liver and replaces
MAT1A in hepatocarcinoma cells [4–6]. The
existence of a liver-specific enzyme can be
explained from a kinetic and regulatory perspec-
tive by the main role played by this organ in diet-
ary methionine metabolism, a function for which
the product of MAT1A is better suited [2,4,7].
Rat MAT1A and MAT2A promoters have been
cloned, sequenced, and functionally characterized
[8,9]. However the mechanisms responsible for the
tissue-specific expression of these two genes can-
not be completely explained by the presence of
cell-type-specific promoter elements, or by the
action of tissue-specific transcription factors [8,9].
An additional level of information, which can in-
fluence gene expression is conveyed by DNA
methylation at CpG sites [10–12]. Gene-specific
methylation patterns have been inversely corre-
lated with gene activity. In this regard, DNA
methylation may interfere with the binding of
transcription factors and has been associated with
the induction of a repressed state of the chroma-
tin [10,12]. In addition to DNA methylation, core
histone acetylation, a reversible post-translational
modification, has been associated with the tran-
scriptional competence of the gene [13,14]. Fur-
thermore, the discovery that transcriptional
activators have histone acetyl transferase activity
stimulated renewed attention to the role of chro-
matin structure and histone acetylation in gene
regulation [15,16]. Recently these two mechan-
isms, DNA methylation and chromatin acetyl-
ation, have been linked together by the demon-
stration that genomic methylation patterns can in-
fluence histone acetylation, and that the degree of
histone acetylation can change the structure of
the nucleosome and thus modulate chromatin
compaction [14,17,18]. In order to gain more
insight into the mechanisms behind MAT1A and
MAT2A tissue-specific expression we have ana-
lyzed the methylation pattern of both genes and
the acetylation status of histones associated with
these two loci in dierent rat tissues.
2. Materials and methods
2.1. Northern blot analysis
Total RNA from liver, kidney, spleen and
heart tissues was obtained by the guanidinium
thiocyanate method [19]. Aliquots (20 mg) of
total RNA were size fractionated by electrophor-
esis in agarose gels under denaturing conditions,
blotted and fixed on Nytran (Schleicher and
Schuell) membranes using standard procedures.
Blots were prehybridized and hybridized as
described [20]. Rat MAT1A full length cDNA
[21] and a 1147 base pairs cDNA fragment of rat
MAT2A [5,22] were labeled with [a-32P]dCTP
(3000 Ci/mmol; Amersham Pharmacia Biotech)
by random priming using the Megaprime DNA
labeling system (Amersham). The amount and
quality of the loaded RNA samples were evalu-
ated by ethidium bromide staining of the gels.
Membranes were then exposed to X-ray films.
2.2. DNA isolation, methylation analysis and
Southern blot
Genomic DNA from dierent rat tissues was
isolated as described previously [23]. Aliquots of
high molecular weight DNA (20 mg) were
digested to completion with 5 U/mg MspI or
HpaII restriction enzymes (Boehringer Man-
nheim) by incubation at 378C for a total of 6 h
(enzyme was added in two aliquots at 3 h inter-
vals). Samples were electrophoresed on 1% agar-
ose gels and then transferred to Nytran
membranes. Prehybridization and hybridization
with MAT1A and MAT2A cDNA probes were
carried out as described [23].
2.3. Nuclei isolation
Liver and kidney from Wistar rats were placed
in buer A (0.25 M sucrose, 10 mM NaCl, 5 mM
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MgCl2, 2 mM EDTA, 0.2% Triton X-100, 2 mM
p-aminobenzamidine, 1 mM PMSF, 2.5 mg/mL
leupeptin, 1.5 mg/mL chymostatin, 50 mM Tris–
HCl, pH 7.5) at a ratio of 5 ml buer per gram
of tissue. All the steps were carried out at 48C.
Tissues were homogenized on ice and after fil-
tration of the homogenates through 200 and
100 mm nylon filters, nuclei were collected by cen-
trifugation at 1500 g for 5 min and the sediment
was washed twice in buer B (buer A without
Triton and EDTA). Nuclear pellets were resus-
pended in the same buer and placed on a dis-
continuous sucrose gradient (0.75 M/1.75 M) in
buer B. After centrifugation at 10,000 g for
30 min, nuclei were collected from the 1.75 M
sucrose cushion and washed twice with buer B.
2.4. Micrococcal nuclease digestion
Nuclei were resuspended in digestion buer
(0.25 M sucrose, 10 mM NaCl, 3 mM MgCl2,
1 mM CaCl2, 10 mM sodium butyrate, 2 mM p-
aminobenzamidine, 1 mM PMSF, 2.5 mg/mL leu-
peptin, 1.5 mg/mL chymostatin, 50 mM Tris–
HCl, pH 7.5) at a concentration of 5 mg DNA
per ml. Nuclei from the liver were digested with
micrococcal nuclease (Worthington) at 15 U per
mg DNA and nuclei from kidney with 20 U per
mg DNA for 10 min at 378C. The digestion was
stopped by adding EDTA to a final concen-
tration of 5 mM and the samples were cooled on
ice and centrifuged at 12,000 g for 10 min. The
supernatant was saved and the pellet was resus-
pended in lysis buer (0.25 mM EDTA, 10 mM
sodium butyrate, 2 mM p-aminobenzamidine,
1 mM PMSF, 2.5 mg/mL leupeptin, 1.5 mg/mL
chymostatin, 50 mM Tris–HCl, pH 7.5) incu-
bated for 10 min on ice and recentrifuged as
above. The first and second supernatants were
pooled and analyzed on agarose gels to deter-
mine the extent of the micrococcal digestion.
Typically, mononucleosomes account for 40% of
micrococcal digestion products.
2.5. Production of antisera to hyperacetylated
histone H4 and antibody purification
Polyclonal antisera to hyperacetylated H4 were
raised by rabbit immunization with a synthetic
peptide corresponding to residues 3–18 of histone
H4 and acetylated in the e-amino groups of
lysines 5, 8, 12 and 16. The acetylated peptide
was custom-synthesized by Genosys and coupled
to Keyhole Limpet Hemocyanin [24]. The IgG
fraction was purified from the serum by HiTrap
Protein-A FPLC chromatography according to
the manufacturer (Amersham Pharmacia Bio-
tech).
The specific recognition of acetylated histones
by this antibody was tested in two dierent assays.
First by the specific interaction of the antibody
with in vitro acetylated histones blotted onto
nitrocellulose filters, and the lack of reactivity
towards the same amounts of non-acetylated his-
tones. Second, by the ability to specifically immu-
noprecipitate acetylated histones from a mixture
of acetylated and non-acetylated histones, under
the same conditions used for the immunofractio-
nation of nucleosomes described below.
2.6. Immunofractionation of nucleosomes
Immunofractionation of nucleosomes obtained
by micrococcal nuclease digestion of nuclei was
performed essentially as previously described
[25]. FPLC-purified antibody (500 mg of IgG) dis-
solved in fractionation buer (50 mM NaCl,
10 mM sodium butyrate, 1 mM EDTA, 0.2 mM
p-aminobenzamidine, 0.1 mM PMSF, 2.5 mg/mL
leupeptin, 1.5 mg/mL chymostatin, 10 mM Tris–
HCl, pH 7.5) was incubated with 100 mg of pro-
tein A Sepharose prewashed with fractionation
buer. The incubation of the antibody with pro-
tein A Sepharose was carried out at 48C for 3 h
under gentle rotation. The protein A Sepharose
bound-antibody was mixed with 2 mg of soluble
chromatin in a final volume of 3 ml of fraction-
ation buer and incubated overnight with gentle
rotation at 48C. The immunocomplexes were col-
lected by centrifugation (6500 g, 1 min) on a
0.65 mm Ultrafree filter unit (Millipore) and the
filtered through fraction was removed and stored
on ice. Protein A Sepharose beads were washed
eight times with 500 ml of fractionation buer as
before and filtrates were pooled together
(unbound fraction). Antibody-bound fraction
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was eluted from protein A Sepharose by addition
of 400 ml of 1.5% SDS in fractionation buer
and rotated for 15 min at room temperature.
After centrifugation as before, the eluate was
saved and protein A Sepharose was reincubated
for another 15 min period with 400 ml of 0.5%
SDS in fractionation buer. The two eluates
(bound fraction) were pooled. DNA from all
chromatin fractions (input, unbound and bound)
was purified and quantitated by fluorescence with
PicoGreen dye (Molecular Probes).
2.7. Slot-blot and hybridization analysis
DNA samples were denatured in 0.5 M
NaOH, 1.5 M NaCl for 10 min at 378C followed
by 1 min at 958C and then kept on ice. DNA
from each fraction (250 ng) were loaded through
a slot–blot manifold (BioRad) on a Biodyne B
membrane (Pall) prewetted in 2 SSC. The filters
were immersed in denaturation solution for
5 min, neutralized in 1.5 M NaCl, 1 mM EDTA,
0.5 M Tris–HCl, pH 7.5 for 30 s and the mem-
branes were dried by baking at 808C for 30 min.
Hybridizations were carried out using MAT1A or
MAT2A cDNA probes mentioned above. The
probes were labeled by random priming. Filters
were prehybridized for 2 h and hybrydized over-
night using Quick Hyb solution (Stratagene) at
658C in the presence of 200 mg of heat-denatured
salmon sperm DNA. Filters were rinsed in 2
SSC, 0.1% SDS and washed sequentially twice
with 2 SSC, 0.1% SDS at 658C for 5 min, once
with 2 SSC, 0.1% SDS at 658C for 30 min and
once with 0.2 SSC, 0.1% SDS at 658C for
20 min. The radioactivity present in the filters
was initially measured with an InstantImager
(Packard) and the filters were then autoradio-
graphed.
3. Results and discussion
Digestion of genomic DNA using the methyl-
ation-sensitive restriction isoschizomers MspI and
HpaII, and subsequent Southern blot analysis
allowed us to evaluate the methylation status of
MAT1A and MAT2A in dierent tissues [26].
Both restriction enzymes recognize the sequence
CCGG, but HpaII cannot cleave if the internal C
is methylated, whereas MspI is not aected by
this modification [27]. In the case of MAT1A,
shown in Fig. 1A, the restriction pattern
observed in the four tissues tested was identical
when genomic DNA was digested with MspI.
However after complete digestion with HpaII a
distinct pattern was obtained in the case of liver
DNA. The appearance of new bands (shown by
asterisks in Fig. 1A) is consistent with hypo-
methylation of MAT1A in this tissue. These
bands were absent in kidney, heart or spleen
samples, tissues in which the MAT1A gene is
silenced as previously reported [2] and as can be
observed in the Northern blot shown in the
lower panel of Fig. 1A. A large body of exper-
imental evidence supports the existence of a re-
lationship between DNA methylation and gene
expression, in the sense that nonmethylated CpG
sequences located either in the 5 ’ regions or in
the complete sequence of genes can mark them
for expression [10]. Conversely, DNA methyl-
ation has been proposed to favor a condensed
and inactive state of the chromatin resulting in
gene silencing [10–12]. Our finding of MAT1A
being hypomethylated in the liver contributes to
the understanding of the tissue-restricted ex-
pression of this gene. Additionally, this situation
may explain why the MAT1A promoter was able
to drive reporter gene expression upon transient
transfection not only in liver type cells such as
the rat hepatoma H35, but also in the non-hepa-
tic CHO cells, in which the endogenous MAT1A
gene is silenced [8].
We have also examined the MAT2A methyl-
ation status in the liver and non-hepatic tissues
using the same approach described for MAT1A.
The results shown in Fig. 1B indicate that
MAT2A, which is widely expressed outside the
liver (as shown in the lower panel of Fig. 1B), is
hypomethylated in all expressing tissues so far
examined, while hypermethylated in liver. This is
supported by the appearance or increased rep-
resentation of two bands in the HpaII treated
DNA samples from kidney, heart or spleen (indi-
cated by asterisks), and by the disappearance of
another band present in HpaII treated DNA
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from liver (marked with an arrowhead). The
MAT2A promoter contains a large G+C rich
domain characteristic of housekeeping genes
[9,10]. These CpG islands are usually free of
methylated cytosines, but if methylated the gene
is rendered inactive [10,28]. Our observations
demonstrate that MAT1A and MAT2A display a
methylation pattern which closely correlates with
their expression profile. Although these findings
alone cannot explain the tissue distribution of
Fig. 1. Methylation status of MAT1A (A) and MAT2A (B) in rat tissues. DNA was extracted from the indicated rat tissues and
digested to completion with either MspI (M) or HpaII (H) and analyzed by Southern blotting as described in Section 2. Asterisks
indicate the location of new or more represented bands detected after digestion with HpaII, indicating hypomethylation at the in-
ternal C of CCGG sites. Arrowhead in part B indicates a band present in the HpaII treated DNA from liver which is lost upon
digestion with this enzyme in all other tissues examined, supporting the hypomethylation of MAT2A outside the liver. Lower
panels show the expression of either MAT1A (A) or MAT2A (B) in the dierent rat tissues as analyzed by Northern blotting.
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both MAT genes it is known that the pattern of
DNA methylation can influence the chromatin
structure formed around a gene [10,11,28] and
that the inactive chromatin structure associated
with DNA methylation is important for the loss
of transcriptional activity [12].
Histone acetylation is a reversible covalent
modification which has been associated with
transcriptional activation [15,16,29,30]. Immuno-
precipitation experiments using antibodies
specific for acetylated histones have demonstrated
that these modified histones are present on po-
tentially and transcriptionally active chromatin,
but not on permanently repressed chromatin [31].
We wanted to know the degree of acetylation dis-
played in vivo by histones associated with
MAT1A and MAT2A genes in liver and kidney,
and whether this covalent modification correlated
with the degree of methylation. For this purpose
nucleosomes obtained from both tissues were
Fig. 2. Histone acetylation of MAT1A (A) and MAT2A (B) chromatin in rat liver and kidney. Nucleosomes from liver and kidney
were obtained and immunoprecipitated with antibodies specific to acetylated histone H4. Equal amounts of DNA from input,
unbound and bound fractions were slot–blotted and filters were hybridized with MAT1A (autoradiograph in panel A) or MAT2A
(autoradiograph in panel B) probes as described in Section 2. Graphics show the degree of enrichment obtained by quantitation of
the radioactivity present in each fraction relative to the signal obtained in the input fraction for each gene in the two tissues exam-
ined.
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immunoprecipitated with an antibody mainly
specific to hyperacetylated histone H4 as
described in Materials and Methods. DNA was
extracted from the ‘‘input’’, ‘‘unbound’’ and
‘‘bound’’ fractions, equal amounts were slot–
blotted onto nylon membranes and hybridized
with MAT1A or MAT2A cDNA probes. The
intensity of the signal obtained from the anti-
body-bound fraction relative to the signal from
the input fraction gives the degree of enrichment
generated by the antibody selection. In the case
of MAT1A a two-fold enrichment was observed
in the acetylated fraction (bound fraction) rela-
tive to input fraction (bulk chromatin) in liver
tissue, while no enrichment was found in the case
of kidney (Fig. 2A). Conversely, MAT2A was
preferentially associated to acetylated histones in
kidney (3.5-fold enrichment) and showed no
enrichment in liver tissue (Fig. 2B). Hence,
MAT1A and MAT2A display a pattern of tissue-
specific histone acetylation which closely corre-
lates with their expression profiles. This is con-
sistent with previous observations showing that
transcriptionally active chromatin is associated
with enhanced histone acetylation levels [12,31].
Until recently it was not completely under-
stood how cytosine methylation patterns could
perform their proposed function controlling tran-
scriptional activity. Several mechanisms have
been proposed, they included the direct modu-
lation of chromatin structure by DNA methyl-
ation [28], the interference with binding of
transcription factors [10], and the implication of
methylated-DNA binding proteins that would
induce the formation of an inactive chromatin
structure [10,11]. However the molecular link
between methyl groups on the DNA and the
modification of chromatin remained elusive. This
mechanism has been recently exposed and
appears to involve the recruitment of histone
deacetylases by methylated-DNA binding pro-
teins such as MeCP2 [14,17]. Histone acetylation
patterns would then be modeled by the under-
lying DNA methylation profile [18]. It has been
proposed that deacetylated histones can establish
closer interactions with DNA and between adja-
cent nucleosomes, thus favoring a condensed and
inactive chromatin [32]. Our present findings
demonstrate that both MAT genes possess a dis-
tinct methylation profile, which probably dictates
the accompanying histone acetylation pattern
found in expressing and non expressing tissues
for each gene. These structural dierences may
be of importance in determining the tissue-
specific expression of MAT1A and MAT2A. In
addition, changes in the DNA methylation and
histone acetylation pattern of both genes could
participate in the developmental regulation of
MAT1A and MAT2A expression in liver, as well
as in their abnormal expression observed in hepa-
tocarcinoma. Furthermore, we have recently pro-
vided evidence supporting a functional role for
DNA methylation and histone acetylation in the
case of MAT1A expression, by showing that 5-
aza-2 ’ deoxycytidine (a DNA demethylating
agent) and trichostatin A (an inhibitor of histone
deacetylases) were able to restore MAT1A ex-
pression in hepatoma cells [33].
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